SANTA ROSA, Calif., June 30, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) today announced the company was added to the Russell 2000 and Russell 3000 Indexes following the reconstitution of Russell Investment Group's family of U.S. indexes after market close on June 27, 2014.
The Russell 2000 Index measures the performance of the small-cap segment of the U.S. equity market and is a subset of the Russell 3000, representing approximately 10 percent of the total market capitalization of that index. Membership in the Russell 2000 Index includes automatic inclusion in the appropriate growth and style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $5.2 trillion in assets are benchmarked to the Russell Indexes.
About Russell - Russell Investments (Russell) is a global asset manager and one of only a few firms that offers actively managed multi-asset portfolios and services that include advice, investments and implementation. Russell stands with institutional investors, financial advisors and individuals working with their advisors—using the firm's core capabilities that extend across capital market insights, manager research, portfolio construction, portfolio implementation and indexes to help each achieve their desired investment outcomes.
About TriVascular Technologies, Inc. - TriVascular is a medical device company developing and commercializing innovative technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company manufactures the Ovation Prime® Abdominal Stent Graft System, the lowest profile FDA-approved endovascular aortic repair system, which utilizes a novel, polymer-based sealing mechanism. TriVascular is based in Santa Rosa, California.